The Lyme ImmunoBlot is a qualitative assay that detects antibodies to B. burgdorferi strains and species. This test includes IgG and IgM antibodies. IgM antibodies may be present as early as 1 week after a tick bite and will usually remain present for six to eight weeks after initial exposure. IgG antibodies are typically present a few months following initial infection. This test is unavailable for patients over 65 when ordered through physician services.
Lyme ImmunoBlot IgM by IGeneX
Serum
The Lyme ImmunoBlot IgM is a qualitative assay that detects IgM antibodies to B. burgdorferi strains and species. The IgM ImmunoBlot may be positive as early as 1 week after a tick bite and will usually remain positive for six to eight weeks after initial exposure. This test is unavailable for patients over 65 when ordered through physician services.
Tick Borne Disease Panel 4IB (TBD4IB) by IGeneX
Whole Blood
Serum
This panel is designed to detect multiple tickborne diseases. It combines 12 tests to detect Lyme Disease, TBRF, Bartonellosis, Babesiosis, Rickettsiosis, Anaplasmosis, and Ehrlichiosis. This test is unavailable for patients over 65 when ordered through physician services.
Lyme Serology IgG/IgM by IGeneX
Serum
The IgG/IgM Antibody Serology test looks for both IgG and IgM antibodies to B. burgdorferi. IgM antibodies are present shortly after infection. IgG antibodies often persist long after symptoms have disappeared. A positive or equivocal test should be confirmed by both IgG and IgM ImmunoBlots. This test is recommended at least four weeks after exposure. This test is unavailable for patients over 65 when ordered through physician services.
Lyme ImmunoBlot Panel 1 (IB1) by IGeneX
Serum
This panel is designed to detect Lyme disease. It combines three tests: Lyme IgG/IgM/IgA Screen, Lyme ImmunoBlot IgM, and Lyme ImmunoBlot IgG. This test is unavailable for patients over 65 when ordered through physician services.